Log in

002907 Chongqing Pharscin Pharmaceutical Co., Ltd. SZSE · China

Chongqing Pharscin Pharmaceutical Co. (002907) news

Chongqing Pharscin Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002907, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Chongqing Pharscin Pharmaceutical Co. news

We have not published a story on Chongqing Pharscin Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Chongqing Pharscin Pharmaceutical Co.

What is the ticker symbol of Chongqing Pharscin Pharmaceutical Co.?

Chongqing Pharscin Pharmaceutical Co., Ltd. trades under the ticker 002907 on SZSE.

Where is Chongqing Pharscin Pharmaceutical Co. listed?

Chongqing Pharscin Pharmaceutical Co., Ltd. is listed on SZSE.

Which country or territory is Chongqing Pharscin Pharmaceutical Co. listed under?

Our directory records Chongqing Pharscin Pharmaceutical Co., Ltd. under China.

What does Chongqing Pharscin Pharmaceutical Co. do?

Our directory classifies Chongqing Pharscin Pharmaceutical Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Chongqing Pharscin Pharmaceutical Co.?

The ISIN recorded for Chongqing Pharscin Pharmaceutical Co., Ltd. is CNE100003308.

Does aibio.space cover Chongqing Pharscin Pharmaceutical Co.?

aibio.space lists Chongqing Pharscin Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Chongqing Pharscin Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Chongqing Pharscin Pharmaceutical Co.: Guizhou Bailing Group Pharmaceutical Co., Golden Throat Holdings Group Co, Ascentage Pharma Group International, BGM Group, Fuan Pharmaceutical (Group) Co., Guiyang Xintian Pharmaceutical Co..

Investor discussion: Chongqing Pharscin Pharmaceutical Co.

Members talk about Chongqing Pharscin Pharmaceutical Co. (002907). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:002907 on TradingView.

Listing details

Chongqing Pharscin Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002907, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Chongqing Pharscin Pharmaceutical Co., Ltd.
Ticker
002907
Listing
SZSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE100003308
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.